Is Spinal Cord Stimulation Worth Trying?

Share this article📱 SMS ✉️ Email 📘 Facebook 💼 LinkedIn ✖️ X 💬 WhatsApp 🔗 Copy Link

Is spinal cord stimulation worth it? For carefully selected people with refractory neuropathic or mixed pain, an SCS trial can be a reasonable next step after other appropriate care. Stimulation manages pain signals. It does not fix the structural spine problem. A trial that fails means you usually skip a permanent implant. This page answers the trust question; the service details live on our spinal cord stimulation hub.

Quick Answer: Is SCS Worth Trying?

SCS can be worth a trial for selected refractory neuropathic or mixed pain after other suitable treatments.
It manages pain signals—it does not repair discs, stenosis anatomy, or instability.
A temporary trial comes first; if it does not help enough, you typically do not implant.
Poor fit examples include active infection, inability to use the device, untreated major barriers your team identifies, or expecting a structural “cure.”
Related option for some patterns: DRG vs SCS.

Table of Contents

What “Worth It” Means Here

“Worth it” means a realistic chance that pain and daily function improve enough to matter to you—not a promise of being pain-free, and not a claim that SCS replaces every other treatment. Goals are personal: walking farther, sleeping better, using fewer breakthrough medicines when safe, or returning to valued activities. Physical therapy often remains a partner for function.

Who May Be a Candidate

Selection themes from evidence-based consensus guidance include chronic non-cancer pain with a neuropathic or mixed phenotype, inadequate relief from appropriate non-implant care, a reasonably clear diagnosis, and the ability to complete a trial and long-term device care [Source]. Conditions often discussed in this pathway include persistent pain after spine surgery (post-laminectomy syndrome), selected radicular patterns, carefully chosen chronic back pain phenotypes, complex regional pain syndrome, and medically refractory painful diabetic neuropathy where labeling and evaluation support neuromodulation [Source] [Source].

Randomized and follow-up studies comparing SCS with conventional medical management in failed-back-surgery pain patterns support considering SCS in selected patients after other care—not as a first treatment for a new disc herniation [Source] [Source]. Waveform choices (including higher-frequency programs studied against traditional stimulation) are individualized; trial titles that use “superior” language describe those study comparisons, not a guarantee for every person [Source].

Who Usually Should Not Proceed Yet

Teams typically pause or decline when there is active infection at the surgical site, an inability to operate or charge the system as required, expectations that SCS will “cure” a structural problem, or major untreated psychosocial barriers that guidelines say should be screened before implant [Source]. Unstable medical illness that makes elective implantation unsafe also needs attention first. Your team will explain which of these factors apply to you before a trial is scheduled.

Ready to Take The Next Step?

Book an appointment with
Dr. Amit Sharma & our minimally invasive pain & spine team.

Book Online Text Us Call Us

Same-day and urgent appointments are often available.

The Trial Comes First

Except in rare labeled exceptions discussed in guidelines, a temporary trial precedes permanent implant for most chronic non-cancer pain indications [Source]. During the trial, leads are placed and connected to an external generator so you can judge pain and function in daily life. Details: spinal cord stimulator trial. What counts as “enough” relief is a shared decision with your care team.

SCS vs Fixing the Spine Problem

If the anatomy still needs decompression or fusion, that conversation belongs with interventional and surgical partners using the structural pathway—see treatments before spine surgery. Neuromodulation and structural care are different tools. Surgeons are partners, not rivals.

DRG Stimulation — Related, Not Identical

Dorsal root ganglion stimulation may fit some focal neuropathic patterns differently than dorsal-column SCS. Short comparison: DRG stimulation vs spinal cord stimulation.

Recovery and Daily Life Snapshot

After implant, activity limits, wound care, and programming follow the surgical plan and device instructions. Overview: spinal cord stimulator recovery. Driving and work clearance are individualized.

Risks to Weigh

Risks include infection, lead migration or fracture, pain at the battery site, need for revision or explant, and the possibility that pain relief is less than hoped even after a promising trial. Discuss device-specific risks with your team before you decide.

Warning Signs

Call 911 or go to the ER for sudden severe weakness, new bowel or bladder loss, high fever with severe back pain, trouble breathing, or rapidly worsening neurologic change. Call 631-310-0000 for non-emergency wound or device questions.

Care at SpinePain Solutions on Long Island

Dr. Amit Sharma, Chief, Division of Pain Medicine at Good Samaritan University Hospital, evaluates neuromodulation candidacy at Bay Shore, Commack, and Farmingdale (office locations). Call or text 631-310-0000.

Questions to Ask Before an SCS Trial

What pain pattern are we trying to help—and what would count as meaningful improvement for me?
Have we given appropriate non-implant care a fair try for my situation?
If the trial helps, what does implant recovery look like for someone like me?
If the trial does not help, what options remain?
How will programming visits work, and who do I call for device problems?
What are the MRI conditions for the specific system being considered?

Write your top three activity goals before the trial week. Pain scores matter, but so does whether you can walk the grocery aisle, sleep through the night, or sit through a meeting. Bring that list to programming visits so adjustments aim at your real life—not only a number on a scale.

What SCS is not

Spinal cord stimulation is not a spine fusion, not a disc removal, and not a guarantee of a pain-free life. It is also not appropriate as the first treatment for a brand-new herniated disc that has not had a fair try of conservative care. People researching online may see strong opinions both for and against neuromodulation. A balanced decision uses your diagnosis, prior care, trial response, and goals—not slogans.

Battery choices, recharge habits, and future MRI needs should be discussed before implant so the system fits your lifestyle. Those details belong in the service and recovery pages once candidacy is clear.

Infection prevention, wound checks, and avoiding early excessive bending or twisting after implant are part of realistic “worth it” planning. A therapy that helps in the trial week but cannot be maintained because device care does not fit your life is not a good long-term match. Be honest with your team about work demands, travel, and who can help in the first weeks after implant.

Frequently Asked Questions

Is spinal cord stimulation worth trying if other treatments failed?

It can be worth a carefully selected trial when chronic neuropathic or mixed pain remains after appropriate other care, the diagnosis fits, and you can participate in device care. SCS manages pain signals; it does not repair a disc herniation or open a narrowed canal. A trial that does not help means you typically skip a permanent implant.

When is pain after stimulation an emergency?

Call 911 or go to the nearest emergency room for sudden severe weakness, new loss of bladder or bowel control, high fever with severe back pain, trouble breathing, or rapidly worsening neurologic change. Call SpinePain Solutions at 631-310-0000 for non-emergency device or wound concerns after a procedure.

Does SCS fix a herniated disc or spinal stenosis?

No. Spinal cord stimulation changes how pain signals are processed. Structural problems may still need separate discussion of decompression, fusion, or other options with the right specialists.

What if the SCS trial fails?

Leads from a temporary trial are removed. You and your doctor discuss other options. A failed trial is useful information—it helps you avoid a permanent implant that is unlikely to meet your goals.

How is DRG stimulation different?

Dorsal root ganglion (DRG) stimulation targets selected nerve-root regions and may fit some focal neuropathic patterns differently than traditional dorsal-column SCS. See DRG vs SCS.

Can I have an MRI later with an SCS system?

MRI access is device- and condition-specific. Some systems allow MRI under labeled conditions; others are more limited. Confirm your exact model and the imaging center’s protocol before any MRI—do not assume every scanner is cleared.